Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Mar 26 01:58PM ET
60.96
Dollar change
+0.16
Percentage change
0.26
%
IndexS&P 500 P/E19.29 EPS (ttm)3.16 Insider Own0.86% Shs Outstand225.56M Perf Week-0.83%
Market Cap13.68B Forward P/E13.15 EPS next Y4.64 Insider Trans-1.27% Shs Float222.47M Perf Month-6.55%
Income744.00M PEG2.48 EPS next Q1.02 Inst Own103.07% Short Float2.64% Perf Quarter-14.92%
Sales4.04B P/S3.39 EPS this Y4.59% Inst Trans-1.19% Short Ratio2.39 Perf Half Y-25.17%
Book/sh21.16 P/B2.88 EPS next Y8.65% ROA8.65% Short Interest5.87M Perf Year-19.00%
Cash/sh8.79 P/C6.93 EPS next 5Y7.79% ROE15.78% 52W Range60.33 - 84.67 Perf YTD-15.44%
Dividend Est.- P/FCF12.10 EPS past 5Y- ROI10.24% 52W High-28.00% Beta0.84
Dividend TTM- Quick Ratio2.78 Sales past 5Y6.10% Gross Margin55.94% 52W Low1.03% ATR (14)1.44
Dividend Ex-Date- Current Ratio3.49 EPS Y/Y TTM50.25% Oper. Margin24.19% RSI (14)38.82 Volatility1.89% 2.24%
Employees7063 Debt/Eq0.53 Sales Y/Y TTM1.75% Profit Margin18.42% Recom2.48 Target Price79.73
Option/ShortYes / Yes LT Debt/Eq0.52 EPS Q/Q-15.61% Payout0.00% Rel Volume0.33 Prev Close60.80
Sales Surprise0.00% EPS Surprise1.47% Sales Q/Q0.86% EarningsFeb 05 AMC Avg Volume2.45M Price60.96
SMA20-1.95% SMA50-7.17% SMA200-18.72% Trades Volume561,177 Change0.26%
Date Action Analyst Rating Change Price Target Change
Mar-03-25Downgrade Argus Buy → Hold
Feb-06-25Downgrade Leerink Partners Outperform → Market Perform $80 → $75
Feb-03-25Downgrade Needham Buy → Hold
Dec-13-24Initiated Wolfe Research Peer Perform
Dec-10-24Reiterated Needham Buy $90
Dec-10-24Initiated Jefferies Hold $85
Oct-01-24Downgrade Citigroup Buy → Neutral $95 → $85
Jun-27-24Initiated Stephens Overweight $87
Apr-03-24Upgrade Citigroup Neutral → Buy $80 → $95
Jul-14-23Upgrade Needham Hold → Buy $95
Mar-24-25 05:45PM
Mar-20-25 11:46AM
Mar-19-25 09:57AM
09:00AM
Mar-17-25 05:45PM
06:58PM Loading…
Mar-13-25 06:58PM
Mar-10-25 05:01AM
Mar-07-25 11:30AM
09:00AM
Mar-04-25 07:37AM
Feb-26-25 04:01AM
Feb-25-25 08:15AM
Feb-24-25 09:00AM
Feb-21-25 12:28PM
08:30AM
05:23AM Loading…
Feb-20-25 05:23AM
03:00AM
Feb-19-25 05:16AM
Feb-18-25 08:08AM
Feb-12-25 08:08AM
Feb-11-25 09:15AM
09:00AM
08:12AM
Feb-07-25 09:40AM
07:21AM
Feb-06-25 09:50AM
09:34AM
08:05AM
02:13AM
Feb-05-25 05:30PM
05:15PM Loading…
05:15PM
04:11PM
04:11PM
04:01PM
Feb-04-25 09:40AM
Jan-31-25 09:15AM
09:00AM
Jan-29-25 10:01AM
Jan-28-25 05:45PM
Jan-22-25 05:45PM
Jan-21-25 08:00AM
Jan-20-25 09:00AM
Jan-16-25 06:38AM
Jan-14-25 05:45PM
Jan-12-25 04:00PM
Jan-08-25 05:45PM
Jan-07-25 04:04PM
09:00AM
Jan-06-25 04:15PM
08:05AM
Jan-03-25 06:46AM
Jan-02-25 05:45PM
Dec-26-24 05:45PM
Dec-24-24 09:00AM
Dec-23-24 12:19PM
Dec-19-24 05:45PM
06:45AM
Dec-18-24 08:08AM
Dec-14-24 06:50AM
Dec-13-24 07:10PM
05:45PM
09:00AM
Dec-10-24 11:10PM
04:01PM
Dec-09-24 04:05PM
08:05AM
Dec-04-24 11:30AM
Dec-02-24 01:29PM
08:08AM
Nov-25-24 08:22AM
Nov-19-24 09:00AM
Nov-14-24 08:08AM
Nov-08-24 12:21PM
09:00AM
Nov-05-24 11:43AM
06:35AM
02:06AM
Nov-04-24 05:30PM
05:15PM
04:20PM
04:01PM
Oct-30-24 09:15AM
Oct-28-24 05:45PM
10:01AM
06:18AM
Oct-25-24 02:57PM
Oct-23-24 09:00AM
06:00AM
Oct-21-24 05:45PM
Oct-15-24 05:45PM
08:05AM
07:32AM
07:02AM
Oct-14-24 02:07PM
08:05AM
Oct-11-24 09:00AM
Oct-09-24 12:10PM
Oct-08-24 05:45PM
Oct-04-24 08:22AM
Oct-02-24 05:45PM
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focuses on women's health and well-being through early detection and treatment. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment is involved in a portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology and treatment. The Diagnostics segment offers a range of products, which are used primarily to aid in the screening and diagnosis of human diseases. The GYN Surgical segment is involved in hysteroscopic endometrial ablation systems, tissue removal systems, fluid management systems, and laparoscopic tissue ablation systems and tools. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mitchell Essex DChief Operating OfficerDec 04 '24Option Exercise62.6022,9021,433,65952,813Dec 06 04:28 PM
Mitchell Essex DChief Operating OfficerDec 04 '24Sale76.3424,8561,897,48227,957Dec 06 04:28 PM
Mitchell Essex DOfficerDec 04 '24Proposed Sale76.3424,8561,897,484Dec 04 12:24 PM
Oberton Karleen MarieChief Financial OfficerAug 29 '24Option Exercise40.9532,8051,343,214136,721Sep 03 04:15 PM
Oberton Karleen MarieChief Financial OfficerAug 29 '24Sale80.5652,6794,243,66284,042Sep 03 04:15 PM
Oberton Karleen MarieOfficerAug 29 '24Proposed Sale80.5652,6794,243,657Aug 29 04:36 PM
Schnittker BrandonDiv. President, GYN SurgicalAug 06 '24Sale83.1147639,5593,735Aug 08 04:08 PM
Schnittker BrandonOfficerAug 06 '24Proposed Sale83.1147639,559Aug 06 04:48 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerAug 01 '24Sale81.995,093417,57010,476Aug 05 04:29 PM
MACMILLAN STEPHEN PChairman, President and CEOJul 30 '24Option Exercise26.2144,0391,154,2621,201,601Aug 01 04:09 PM
MACMILLAN STEPHEN PChairman, President and CEOJul 30 '24Sale81.7044,0393,597,9241,157,562Aug 01 04:09 PM
COHN BENJAMIN JORDANOfficerAug 01 '24Proposed Sale81.995,093417,574Aug 01 03:58 PM
MACMILLAN STEPHEN POfficerJul 30 '24Proposed Sale81.7044,0393,597,894Jul 30 04:29 PM
MACMILLAN STEPHEN PChairman, President and CEOJul 17 '24Option Exercise26.213,67296,2431,161,234Jul 19 04:09 PM
MACMILLAN STEPHEN PChairman, President and CEOJul 17 '24Sale80.133,672294,2231,157,562Jul 19 04:09 PM
Stamoulis ChristianaDirectorJul 17 '24Option Exercise26.749,039241,70354,511Jul 19 04:06 PM
Stamoulis ChristianaDirectorJul 17 '24Sale79.509,039718,60045,472Jul 19 04:06 PM